This video is of the Educational Session that occurred on the 21st of April 2023 about #GeneTherapy for #SickleCell in Africa and the activities by Global Gene Therapy Initiative, featuring Jennifer E Adair

bit.ly/3Hl1FvH

Do you remember when you joined Twitter? I do! #MyTwitterAnniversary

NEW webinar series 2023: discuss the needs and concerns around #HIV cure research for people who have lived with #HIV for many years

Register here: bit.ly/3ZCA4fC

Thanks to Dr. John Tisdale for presenting at our April 21 event entitled - Toward Molecular Cures for The First Molecular Disease, Cell and Gene Therapies for Sickle Cell Disease

You may access the video in our Members Area. Membership is FREE.

👉caringcross.org/become-a-membe…

Proliferation, not replication: #HIV is lifelong because infected cells divide, not only because they infect others.

bit.ly/3od7e8w

#hivcure

Daily statin reduces the risk of cardiovascular disease in people living with #HIV , large NIH study finds nih.gov/news-events/ne… REPRIEVE Trial NIAID News NIH

#sicklecell gene therapies could be cost-effective even if priced as high as $1.9 million!

bit.ly/3MGD4F1

#GeneTherapy

At our March meeting, we learned about a new study of cencriviroc mesylate (CVC) as a potential treatment to add to #HIV regimen to reduce HIV inflammation.
If you're in the Seattle and interested in this study, call or text us at 206-773-7129.

bit.ly/3JZ8kw9

Reposting my DoxyPEP report from #AIDS2022 since results are now published in NEJM. Post-exposure doxycycline as prophylaxis for chlamydia, gonorrhea & syphilis could be a game-changer, esp. for gay men. 1/ poz.com/article/taking…

📣 Applications are due in just 1 week for the 2023 Research-for-Cure Academy.

The academy is designed for people in countries with limited resources for #HIV cure research who are interested in working towards an #HIV cure.

✅ Learn more & apply today! bit.ly/3Ka8xfM

“…we are at a crossroads in the cell and gene therapy industry…decentralization will make cell and gene therapies more attainable for more patients…” -Ø Åmellem, Thermo Fisher director of cell therapy Global Gene Therapy Initiative amfAR Thermo Fisher Cytiva in genengnews.com/topics/bioproc…

Making its debut this May 9-11 in Boston, the Novel Cell Line Engineering & Development Summit unites 60+ industry leaders from Sanofi, AstraZeneca, Takeda, Lonza, and many more as they seek to enhance stable, scalable host cell lines! ter.li/3m2k1x

Join us on Monday 17th April at 6:30pm on Zoom for our next online event 'Let's Talk: Men's Mental Health & Sickle Cell'

Register to join now at: bit.ly/403Uq1I (link in bio)

#sicklecell #sicklecell awareness #mensmentalhealth

#PatientAdvocates : attend a buffet Luncheon at #ASGCT23 organized especially for you—RSVP by April 14. And remember: Eligible patient advocates can apply for FREE registration to the Annual Meeting: annualmeeting.asgct.org/program/networ…

To #sciencejournalists : Register for #ASGCT23 for free + get access to 1,700+ abstracts with the latest #celltherapy & #genetherapy research! Attend the premier event for cell and gene therapy professionals in May virtually/in-person + access on demand: annualmeeting.asgct.org/register/media

The MOXIE trial shows that women are invested in #hivcure research.

bit.ly/3GbWayA

ACTG Network

The MOXIE trial shows that women are invested in #hivcure research.

bit.ly/3GbWayA

ACTG Network

New on our website: why we need more women in #HIVcure studies. A collaborative piece by Dr Mihiri Weerasuria and PositiveWomenVic.

Check it out here!
hivcure.com.au/2023/04/06/why…

'It’s very easy to think that #HIV has gone away, that it’s no longer a big problem. It is still a major #pandemic . People still die. A cure would be transformative.' – IAS President Sharon Lewin

Listen to Episode 5 of #HIV unmuted now: spoti.fi/3rt2Sbp

Viral and Host Mediators of Non-Suppressible #HIV -1 Viremia medrxiv.org/content/10.110… (preprint of study presented at #CROI2023 ) medRxiv